Sepsis Diagnostics Market

Purchase Option

$ 4400
$ 6600
$ 8900

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Sepsis Diagnostics Market Segmentation

1. Executive Summary
2. Global Sepsis Diagnostics Market Introduction
2.1. Global Sepsis Diagnostics Market - Taxonomy
2.2. Global Sepsis Diagnostics Market - Definitions
2.2.1. Technology
2.2.2. Product
2.2.3. Indication
2.2.4. End User
2.2.5. Region
3. Global Sepsis Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Global Sepsis Diagnostics Market By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. Microbiology
4.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Molecular Diagnosis
4.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. Immunoassays
4.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
4.4. Flow Cytometry
4.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.4.3. Market Opportunity Analysis
5. Global Sepsis Diagnostics Market By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Blood Culture Media
5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Assays & Reagents
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Sepsis Diagnostics Market By Indication, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Bacterial Sepsis
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Fungal Sepsis
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Acute Kidney Injury
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Sepsis Diagnostics Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals & Clinics
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Home Care Settings
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Research laboratories
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Sepsis Diagnostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Sepsis Diagnostics Market - Opportunity Analysis Index, By Product, Technology, Indication, End User, and Region, 2023-2029
9. North America Sepsis Diagnostics Market , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Microbiology
9.1.2. Molecular Diagnosis
9.1.3. Immunoassays
9.1.4. Flow Cytometry
9.2. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Blood Culture Media
9.2.2. Instruments
9.2.3. Assays & Reagents
9.3. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. Bacterial Sepsis
9.3.2. Fungal Sepsis
9.3.3. Acute Kidney Injury
9.3.4. Others
9.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.4.1. Hospitals & Clinics
9.4.2. Home Care Settings
9.4.3. Research laboratories
9.4.4. Others
9.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.5.1. USA
9.5.2. Canada
10. Europe Sepsis Diagnostics Market , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Microbiology
10.1.2. Molecular Diagnosis
10.1.3. Immunoassays
10.1.4. Flow Cytometry
10.2. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Blood Culture Media
10.2.2. Instruments
10.2.3. Assays & Reagents
10.3. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. Bacterial Sepsis
10.3.2. Fungal Sepsis
10.3.3. Acute Kidney Injury
10.3.4. Others
10.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospitals & Clinics
10.4.2. Home Care Settings
10.4.3. Research laboratories
10.4.4. Others
10.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.5.1. Germany
10.5.2. France
10.5.3. Italy
10.5.4. Spain
10.5.5. UK
10.5.6. Rest of Europe
11. Asia Pacific Sepsis Diagnostics Market , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Microbiology
11.1.2. Molecular Diagnosis
11.1.3. Immunoassays
11.1.4. Flow Cytometry
11.2. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Blood Culture Media
11.2.2. Instruments
11.2.3. Assays & Reagents
11.3. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Bacterial Sepsis
11.3.2. Fungal Sepsis
11.3.3. Acute Kidney Injury
11.3.4. Others
11.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospitals & Clinics
11.4.2. Home Care Settings
11.4.3. Research laboratories
11.4.4. Others
11.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.5.1. China
11.5.2. Japan
11.5.3. South Korea
11.5.4. India
11.5.5. Rest of APAC
12. Latin America Sepsis Diagnostics Market , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.1.1. Microbiology
12.1.2. Molecular Diagnosis
12.1.3. Immunoassays
12.1.4. Flow Cytometry
12.2. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.2.1. Blood Culture Media
12.2.2. Instruments
12.2.3. Assays & Reagents
12.3. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.3.1. Bacterial Sepsis
12.3.2. Fungal Sepsis
12.3.3. Acute Kidney Injury
12.3.4. Others
12.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospitals & Clinics
12.4.2. Home Care Settings
12.4.3. Research laboratories
12.4.4. Others
12.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
13. MEA Sepsis Diagnostics Market , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.1.1. Microbiology
13.1.2. Molecular Diagnosis
13.1.3. Immunoassays
13.1.4. Flow Cytometry
13.2. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.2.1. Blood Culture Media
13.2.2. Instruments
13.2.3. Assays & Reagents
13.3. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.3.1. Bacterial Sepsis
13.3.2. Fungal Sepsis
13.3.3. Acute Kidney Injury
13.3.4. Others
13.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospitals & Clinics
13.4.2. Home Care Settings
13.4.3. Research laboratories
13.4.4. Others
13.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Roche Diagnostics
14.2.2. Becton, Dickinson and Company
14.2.3. Abbott
14.2.4. BioMérieux
14.2.5. SphingoTec GmbH
14.2.6. Danaher
14.2.7. NanoDx, Inc.
14.2.8. Luminex
14.2.9. Immunexpress
14.2.10. Cepheid Inc
14.2.11. Bruker
14.2.12. Quidel Corporation
15. Research Methodology
16. Key Assumptions and Acronyms
• Roche Diagnostics
• Becton, Dickinson and Company
• Abbott
• BioMérieux
• SphingoTec GmbH
• Danaher
• NanoDx, Inc.
• Luminex
• Immunexpress
• Cepheid Inc
• Bruker
• Quidel Corporation

Adjacent Markets